Collaborative Consortium to Address Encapsulation for Beta Cell Replacement

Agency: 
JDRF

JDRF is soliciting EOIs to encourage collaborations among bioengineers, chemists, immunologists, transplant researchers, and pancreatic beta cell biologists to incorporate engineering concepts and designs into current efforts toward improving islet encapsulation as a key component of cell replacement therapy for T1D. Ultimately, the funded projects should have established milestones and make progress toward making encapsulated human islets/porcine islets/hESC-derived pancreatic progenitors a translatable technology applicable in the clinical setting.

Deadline: 
March 26, 2012

Last updated January 03, 2012